Latterell Venture Partners is a private equity general partner firm headquartered in San Francisco, CA, United States.
Viracta Therapeutics held an initial closing of a Series B financing round of up to $18.4m with support from Latterell Ventures and others.
Transcend Medical, a US-based developer of glaucoma procedures, has raised $22m in Series C funds from Split Rock Partners and others.
VC-backed TetraLogic Pharmaceuticals has appointed J. Kevin Buchi as its new president and CEO.
Read more news concerning Latterell Venture Partners
A sampling of Latterell Venture Partners portfolio companies:
View all of the investments in their portfolio
Registration is fast, free and easy
Already a member?